# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001564590-19-017283
Filing Date
2019-05-08
Accepted
2019-05-08 16:48:32
Documents
36
Period of Report
2019-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | abio-8k_20190508.htm | 8-K | 38084
2 | EX-99.1 | abio-ex991_6.htm | EX-99.1 | 110176
3 | EX-99.2 | abio-ex992_33.htm | EX-99.2 | 32888
4 | GRAPHIC | gd1efnzuqbwb000026.jpg | GRAPHIC | 294468
5 | GRAPHIC | gd1efnzuqbwb000021.jpg | GRAPHIC | 274332
6 | GRAPHIC | gd1efnzuqbwb000008.jpg | GRAPHIC | 315365
7 | GRAPHIC | gd1efnzuqbwb000006.jpg | GRAPHIC | 281360
8 | GRAPHIC | gd1efnzuqbwb000032.jpg | GRAPHIC | 464303
9 | GRAPHIC | gd1efnzuqbwb000029.jpg | GRAPHIC | 211756
10 | GRAPHIC | gd1efnzuqbwb000001.jpg | GRAPHIC | 473190
11 | GRAPHIC | gd1efnzuqbwb000023.jpg | GRAPHIC | 265825
12 | GRAPHIC | gd1efnzuqbwb000013.jpg | GRAPHIC | 301333
13 | GRAPHIC | gd1efnzuqbwb000016.jpg | GRAPHIC | 305393
14 | GRAPHIC | gd1efnzuqbwb000014.jpg | GRAPHIC | 362077
15 | GRAPHIC | gd1efnzuqbwb000012.jpg | GRAPHIC | 363028
16 | GRAPHIC | gd1efnzuqbwb000004.jpg | GRAPHIC | 312094
17 | GRAPHIC | gd1efnzuqbwb000015.jpg | GRAPHIC | 274263
18 | GRAPHIC | gd1efnzuqbwb000025.jpg | GRAPHIC | 376530
19 | GRAPHIC | gd1efnzuqbwb000024.jpg | GRAPHIC | 238363
20 | GRAPHIC | gd1efnzuqbwb000005.jpg | GRAPHIC | 257561
21 | GRAPHIC | gd1efnzuqbwb000020.jpg | GRAPHIC | 289873
22 | GRAPHIC | gd1efnzuqbwb000030.jpg | GRAPHIC | 135448
23 | GRAPHIC | gd1efnzuqbwb000027.jpg | GRAPHIC | 240633
24 | GRAPHIC | gd1efnzuqbwb000028.jpg | GRAPHIC | 329760
25 | GRAPHIC | gd1efnzuqbwb000003.jpg | GRAPHIC | 327880
26 | GRAPHIC | gd1efnzuqbwb000011.jpg | GRAPHIC | 278741
27 | GRAPHIC | gd1efnzuqbwb000002.jpg | GRAPHIC | 517883
28 | GRAPHIC | gd1efnzuqbwb000010.jpg | GRAPHIC | 261379
29 | GRAPHIC | gd1efnzuqbwb000018.jpg | GRAPHIC | 305812
30 | GRAPHIC | gd1efnzuqbwb000007.jpg | GRAPHIC | 328326
31 | GRAPHIC | gd1efnzuqbwb000009.jpg | GRAPHIC | 244095
32 | GRAPHIC | gd1efnzuqbwb000022.jpg | GRAPHIC | 275701
33 | GRAPHIC | gg5wdm35o5o0000001.jpg | GRAPHIC | 20861
34 | GRAPHIC | gd1efnzuqbwb000017.jpg | GRAPHIC | 333137
35 | GRAPHIC | gd1efnzuqbwb000031.jpg | GRAPHIC | 328315
36 | GRAPHIC | gd1efnzuqbwb000019.jpg | GRAPHIC | 366293
| Complete submission text file | 0001564590-19-017283.txt |  | 13896427

Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 19807354
SIC: 2835 In Vitro & In Vivo Diagnostic Substances